A retrospective review of patients unable to take medications by mouth showed short interruptions of therapy for most patients. In a secondary analysis, our data showed maintenance and/or achievement of viral suppression for most patients. A retrospective review of intensive care patients unable to take antiretrovirals by mouth showed 56.6% of patients experiencing a transient interruption in therapy. Additionally, our case series further supports previous literature on crushing dolutegravir and bictegravir regimens to maintain and achieve viral suppression.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10712287PMC
http://dx.doi.org/10.1093/ofid/ofad554DOI Listing

Publication Analysis

Top Keywords

medications mouth
8
retrospective review
8
patients unable
8
viral suppression
8
patients
6
evaluation dolutegravir-
4
dolutegravir- bictegravir-based
4
bictegravir-based antiretroviral
4
antiretroviral regimen
4
regimen utilization
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!